JP2009523739A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523739A5
JP2009523739A5 JP2008550594A JP2008550594A JP2009523739A5 JP 2009523739 A5 JP2009523739 A5 JP 2009523739A5 JP 2008550594 A JP2008550594 A JP 2008550594A JP 2008550594 A JP2008550594 A JP 2008550594A JP 2009523739 A5 JP2009523739 A5 JP 2009523739A5
Authority
JP
Japan
Prior art keywords
gene
bone
c1qtnf3
rbp4
anxa3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008550594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523739A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2007/000055 external-priority patent/WO2007082352A1/en
Publication of JP2009523739A publication Critical patent/JP2009523739A/ja
Publication of JP2009523739A5 publication Critical patent/JP2009523739A5/ja
Pending legal-status Critical Current

Links

JP2008550594A 2006-01-20 2007-01-19 骨の病変の処置、予防、および診断の方法 Pending JP2009523739A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2006900307A AU2006900307A0 (en) 2006-01-20 Method of treatment and diagnosis
PCT/AU2007/000055 WO2007082352A1 (en) 2006-01-20 2007-01-19 Method of treatment, prophylaxis and diagnosis of pathologies of the bone

Publications (2)

Publication Number Publication Date
JP2009523739A JP2009523739A (ja) 2009-06-25
JP2009523739A5 true JP2009523739A5 (enExample) 2010-03-04

Family

ID=38287201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550594A Pending JP2009523739A (ja) 2006-01-20 2007-01-19 骨の病変の処置、予防、および診断の方法

Country Status (8)

Country Link
US (1) US20100330085A1 (enExample)
EP (1) EP1991274A4 (enExample)
JP (1) JP2009523739A (enExample)
CN (1) CN101426536A (enExample)
AU (1) AU2007207341B2 (enExample)
CA (1) CA2637350A1 (enExample)
NZ (1) NZ569697A (enExample)
WO (1) WO2007082352A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0707349D0 (en) * 2007-04-17 2007-05-23 Renovo Ltd Medicaments and methods for accelerating wound healing
EP2167976A2 (en) * 2007-05-29 2010-03-31 President And Fellows Of Harvard College Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
JP5694776B2 (ja) * 2007-12-11 2015-04-01 エピゲノミクス アーゲー 細胞増殖性障害の解析のための方法及び核酸
EP2245459A1 (en) 2008-01-23 2010-11-03 Herlev Hospital Ykl-40 as a general marker for non-specific disease
US8580520B2 (en) 2008-09-15 2013-11-12 Herlev Hospital YKL-40 as a marker for gastrointestinal cancers
GB0922085D0 (en) * 2009-12-17 2010-02-03 Cambridge Entpr Ltd Cancer diagnosis and treatment
WO2011088163A1 (en) 2010-01-14 2011-07-21 President And Fellows Of Harvard College Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
EP2556379B1 (en) * 2010-10-28 2014-07-09 Avicenna Research Institute A 38 kda form of prelp as new diagnosis and therapeutic target
US20140155420A1 (en) * 2011-01-10 2014-06-05 The Regents Of The University Of Colorado, A Body Corporate Inhibitors of eya2
CN103517717B (zh) * 2011-02-16 2017-10-17 康奈尔大学 增强细胞介导的免疫的方法
AU2012253204A1 (en) * 2011-05-06 2013-04-18 Women's And Children's Health Research Institute Inc Method of treatment and prophylaxis of pathologies of the bone
CN109295218B (zh) * 2018-12-11 2020-05-19 南京医科大学 环状RNA标志物hsa_circ_0001788及其应用
CN114015767B (zh) * 2021-11-18 2023-06-02 南京市儿童医院 一种鉴别颅缝早闭的血清circRNA标志物及其应用
CN114657121B (zh) * 2022-03-23 2023-07-25 新乡医学院 LOX1基因作为流体剪切力作用下BMSCs成骨分化促进剂的应用
CN114774546B (zh) * 2022-04-27 2023-04-18 江苏省人民医院（南京医科大学第一附属医院） 一种与人骨肉瘤相关的分子标记物trim22及其应用
CN116217721A (zh) * 2023-02-16 2023-06-06 复旦大学附属中山医院 一种C14orf78免疫组织化学抗体及其制备方法与应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4018884A (en) 1975-06-26 1977-04-19 Hoffmann-La Roche Inc. Fluorogenic materials and labeling techniques
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4897255A (en) 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4744981A (en) 1985-10-17 1988-05-17 Neorx Corporation Trichothecene antibody conjugates
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
EP0329184A3 (en) 1988-02-19 1990-05-23 Neorx Corporation Antimers and antimeric conjugation
US4988496A (en) 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
EP0438803B1 (en) 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccines against cancer and infectious diseases
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
GB9022788D0 (en) 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
DE69132531T2 (de) 1990-12-06 2001-09-13 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verbindungen und ihre Verwendung in einer binären Synthesestrategie
US5283185A (en) 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5854217A (en) 1992-09-28 1998-12-29 Bearsden Bio, Inc. Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5908635A (en) 1994-08-05 1999-06-01 The United States Of America As Represented By The Department Of Health And Human Services Method for the liposomal delivery of nucleic acids
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US6096716A (en) 1994-12-12 2000-08-01 The Board Of Regents, The University Of Texas System Liposome-mediated transfection of central nervous system cells
WO2003022300A1 (en) * 2001-09-10 2003-03-20 Takeda Chemical Industries, Ltd. Preventives/remedies for bone/joint diseases
AU2003300395A1 (en) * 2002-12-24 2004-07-22 Amgen Inc. Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof
EP1620567A1 (en) * 2003-04-15 2006-02-01 Hans-Jürgen Thiesen Method for diagnosing rheumatoid arthritis or osteoarthritis
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
US7485657B2 (en) * 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
DE602005024502D1 (de) * 2004-07-09 2010-12-16 Chugai Pharmaceutical Co Ltd Anti-glypican-3-antikörper

Similar Documents

Publication Publication Date Title
JP2009523739A5 (enExample)
Soria-Valles et al. The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21
Zhao et al. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice
Morita et al. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma
Ghalhar et al. Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer
US11236341B2 (en) RNA aptamers against transferrin receptor (TFR)
WO2014111458A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
WO2013027120A3 (en) Method and system for disease risk management
US20210123101A1 (en) Mirna marker and kit associated with postmenopausal osteoporosis
Spitzer et al. Use of a “hybrid” locking plate for complex metaphyseal fractures and nonunions about the humerus
Zhou et al. H19 promotes the proliferation of osteocytes by inhibiting p53 during fracture healing.
Torres et al. Effect of ovariectomy on inflammation induced by intermittent hypoxia in a mouse model of sleep apnea
Ye et al. Short-wave enhances mesenchymal stem cell recruitment in fracture healing by increasing HIF-1 in callus
Choi et al. Surgical management of extensive osteoradionecrosis in nasopharyngeal carcinoma patients with the maxillary swing approach and free muscular flaps.
Heidari et al. Staphylococcus aureus enterotoxin type B (SEB) and alpha-toxin induced apoptosis in KB cell line
CN105132550B (zh) 检测muc21基因表达的试剂在制备骨关节炎诊治产品中的应用
MX2010008765A (es) Regulacion de expresion de genes de factor de crecimiento de fibroblastos-2 (fgf-2) en celulas vivas con la aplicacion de campos electricos y electromagnetivos especificos y selectivos.
JP2011520781A5 (enExample)
JP2011514813A5 (enExample)
JP2010514421A5 (enExample)
Xiao et al. LIPUS accelerates bone regeneration via HDAC6-mediated Ciliogenesis
EP4327816A1 (en) Method for promoting bone healing using lactiplantibacillus plantarum twk10
US20220396794A1 (en) APTAMERS AGAINST TRANSFERRIN RECEPTOR (TfR)
CN101902980A (zh) 射频场对细胞生长的作用和用于腹腔镜处理的方法
Liu et al. RNA interference against SPARC promotes the growth of U-87MG human malignant glioma cells